[Guidelines of the Swiss Diabetic Association on diabetes and contraception].
D001786:Blood Glucose / Q000032:analysis; D003278:Contraceptives, Oral, Hormonal / Q000009:adverse effects*; D003920:Diabetes Mellitus / Q000097:blood; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000150:complications*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000150:complications*; D004967:Estrogens / Q000008:administration & dosage / Q000009:adverse effects; D005260:Female; D006801:Humans; D009640:Norethindrone / Q000008:administration & dosage; D009644:Norgestrel / Q000009:adverse effects; D009765:Obesity; D011247:Pregnancy; D011254:Pregnancy in Diabetics / Q000517:prevention & control; D012955:Societies, Medical; D013557:Switzerland
D001786:Blood Glucose; D003278:Contraceptives, Oral, Hormonal; D004967:Estrogens; D009644:Norgestrel; D009640:Norethindrone
Directives de l'ASD concernant diabète et contraception.